Target intelligence / Profile preview

Ribulose-5-Phosphate-3-Epimerase Pseudogene 2 (RPEP2)

Target: RPEP2
Molecular classification: Pseudogene

Overview

RPEP2 is a pseudogene that is part of the ribulose-5-phosphate-3-epimerase family. It is a non-coding region of the genome that shares a sequence homologous to the active ribulose-5-phosphate-3-epimerase enzyme, but lacks the functionality due to mutations or sequence disruptions characteristic of pseudogenes. This information highlights that RPEP2 is not considered a therapeutic target due to its lack of functional activity as a pseudogene. However, like other pseudogenes, it may potentially influence gene regulation or expression indirectly.

Other names: RPEP2

Mechanism of action

Not applicable as it is not a functional target

Biological functions

Since RPEP2 is a pseudogene, it is generally considered inactive and does not perform typical biological functions like its active counterparts.However, pseudogenes can sometimes influence gene regulation or expression indirectly

Disease associations

Currently, there is no specific information linking RPEP2 directly to disease roles.

Safety considerations

None known

Interacting drugs

None known

Biomarkers

None known

Beyond the preview

Go deeper on Ribulose-5-Phosphate-3-Epimerase Pseudogene 2 (RPEP2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribulose-5-Phosphate-3-Epimerase Pseudogene 2 (RPEP2).

Explore the full profile